financetom
Business
financetom
/
Business
/
Looking At Celestica's Recent Unusual Options Activity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Looking At Celestica's Recent Unusual Options Activity
Jan 31, 2025 11:50 AM

Investors with a lot of money to spend have taken a bullish stance on Celestica ( CLS ) .

And retail traders should know.

We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.

Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CLS, it often means somebody knows something is about to happen.

So how do we know what these investors just did?

Today, Benzinga's options scanner spotted 79 uncommon options trades for Celestica ( CLS ).

This isn't normal.

The overall sentiment of these big-money traders is split between 54% bullish and 27%, bearish.

Out of all of the special options we uncovered, 6 are puts, for a total amount of $221,804, and 73 are calls, for a total amount of $6,973,170.

Predicted Price Range

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $35.0 to $175.0 for Celestica ( CLS ) over the recent three months.

Volume & Open Interest Trends

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Celestica's ( CLS ) options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Celestica's ( CLS ) whale trades within a strike price range from $35.0 to $175.0 in the last 30 days.

Celestica 30-Day Option Volume & Interest Snapshot

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
CLS CALL SWEEP BULLISH 02/21/25 $26.7 $26.7 $26.7 $105.00 $646.1K 3.4K 804
CLS CALL SWEEP BULLISH 02/21/25 $29.6 $29.5 $29.6 $102.00 $352.2K 301 223
CLS CALL TRADE BULLISH 03/21/25 $29.8 $28.2 $29.65 $105.00 $293.5K 316 115
CLS CALL SWEEP BULLISH 02/21/25 $26.7 $26.6 $26.7 $105.00 $291.0K 3.4K 705
CLS CALL TRADE NEUTRAL 03/21/25 $25.9 $24.6 $25.2 $110.00 $214.2K 775 181

About Celestica

Celestica Inc ( CLS ) offers supply chain solutions. The company has two operating and reportable segments: Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS). The ATS segment consists of the ATS end market and is comprised of the Aerospace and Defense, Industrial, health tech, and Capital Equipment businesses. Its Capital Equipment business is comprised of the semiconductor, display, and robotics equipment businesses, and the CCS segment consists of Communications and Enterprise end markets, Enterprise end market is comprised of its servers and storage businesses. The company generates a majority of its revenue from the Connectivity & Cloud Solutions segment.

In light of the recent options history for Celestica ( CLS ), it's now appropriate to focus on the company itself. We aim to explore its current performance.

Celestica's Current Market Status

Trading volume stands at 8,598,511, with CLS's price up by 12.25%, positioned at $128.13.

RSI indicators show the stock to be is currently neutral between overbought and oversold.

Earnings announcement expected in 82 days.

Expert Opinions on Celestica

4 market experts have recently issued ratings for this stock, with a consensus target price of $125.25.

Turn $1000 into $1270 in just 20 days?

20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.

* Maintaining their stance, an analyst from TD Securities continues to hold a Buy rating for Celestica ( CLS ), targeting a price of $107.

* Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Celestica ( CLS ) with a target price of $115.

* An analyst from RBC Capital persists with their Outperform rating on Celestica ( CLS ), maintaining a target price of $140.

* Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Celestica ( CLS ) with a target price of $139.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Celestica ( CLS ), Benzinga Pro gives you real-time options trades alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Agree Realty Prices Stock Offering at $74 Per Share
Agree Realty Prices Stock Offering at $74 Per Share
Oct 25, 2024
03:54 AM EDT, 10/25/2024 (MT Newswires) -- Agree Realty ( ADC ) said late Thursday it priced a public offering of 4.4 million common shares at $74 per share pursuant to certain forward sale agreements. Underwriters have been granted a 30-day option to purchase up to 660,000 additional shares. Net proceeds, which will be received upon future settlement of the...
Italy's Eni to boost buyback after quarterly earnings beat expectations
Italy's Eni to boost buyback after quarterly earnings beat expectations
Oct 25, 2024
MILAN, Oct 25 (Reuters) - Italian energy group Eni will increase its share buyback programme to 2 billion euros ($2.2 billion), it said on Friday, after beating third-quarter profit expectations. The state-controlled group had indicated in July that it could raise the 1.6-billion-euro programme to up 2.1 billion if the macroeconomic situation improved. It reported an adjusted net profit of...
Sanofi CFO says won't be affected by Novo's Catalent deal
Sanofi CFO says won't be affected by Novo's Catalent deal
Oct 25, 2024
FRANKFURT, Oct 25 (Reuters) - Sanofi's finance chief on Friday said the company won't be affected by Novo Nordisk's controlling shareholder's decision to acquire contract drug manufacturer Catalent ( CTLT ), adding the deal made sense for its rival. They desperately need capacity so it makes sense for them, Sanofi CFO Francois-Xavier Roger said in a media call after the...
Yen vulnerable; dollar eyes fourth straight weekly gain
Yen vulnerable; dollar eyes fourth straight weekly gain
Oct 25, 2024
SINGAPORE (Reuters) -The yen languished near a three-month trough on Friday and was headed for a fourth straight weekly loss, ahead of an election in Japan over the weekend that is likely to complicate the Bank of Japan's (BOJ) policy normalisation plans. In the broader market, the dollar held broadly steady and was on course for yet another weekly gain,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved